wegovy semaglutide or tirzepatide Outperforms in Reducing Major Adverse Cardiovascular Events Tirzepatide vs. Semaglutide for Weight
Description
Taking 60 seconds to gently roll the vial ensures complete, safe dissolution
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
The injection should be administered once weekly on the same day each week, though the specific time of day can be flexible based on patient preference and lifestyle factors

Quick Reference: Standard Protocol Self-reported starting doses begin around 0.25 mg 3x weekly for 2-4 weeks to assess tolerance, before increasing to 0.5 mg 3x weekly

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that mimics the GLP-1 and GIP hormones

This helps you feel fuller longer after eating, which is one of the ways tirzepatide helps with weight loss